Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.360,94
-0,83%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ iTeos Therapeutics Inc (ITOS) iTeos Therapeutics Inc (ITOS) Notizie

iTeos Therapeutics Inc

ITOS
11,66
0,17 (1,48%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/4/202422:30GLOBEiTeos Presents EOS-984 Preclinical Data Demonstrating..
09/3/202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/3/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/3/202401:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/3/202401:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202402:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/3/202413:19EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/3/202413:09EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06/3/202413:01GLOBEiTeos Appoints Oncology Veteran Jill DeSimone to Its Board..
06/3/202413:00GLOBEiTeos Reports Fourth Quarter and Full Year 2023 Financial..
05/3/202422:30GLOBEiTeos to Highlight Preclinical Data on First-In-Class..
01/3/202413:00GLOBEiTeos to Participate in Upcoming Investor Conferences
10/1/202423:00EDGAR2Form 8-K - Current report
08/1/202413:00GLOBEiTeos Announces 2024 Strategic Priorities and Anticipated..
03/1/202413:00GLOBEiTeos to Present at the 42nd Annual J.P. Morgan Healthcare..
08/12/202302:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202302:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202302:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202302:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202302:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202302:16EDGAR2Form 3 - Initial statement of beneficial ownership of..
07/12/202322:11EDGAR2Form 8-K - Current report
21/11/202313:00GLOBEiTeos to Present at the Piper Sandler 35th Annual Healthcare..
07/11/202313:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202313:00GLOBEiTeos Reports Third Quarter 2023 Financial Results and..
12/10/202323:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202323:55PRNUSNCR Atleos Set to Join S&P SmallCap 600
06/9/202313:00GLOBEiTeos to Participate in Upcoming Investor Conferences
08/8/202313:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202313:00GLOBEiTeos Reports Second Quarter 2023 Financial Results and..
10/5/202313:01GLOBEiTeos Reports First Quarter 2023 Financial Results and..
Apertura: 11,72 Min: 11,51 Max: 11,92
Chiusura: 11,49

La tua Cronologia

NASDAQ
ITOS
iTeos Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network